Medicure CEO Dr. Albert Friesen was instrumental in the development of the WinRho drug, one of Canada’s first successful biotech products, which prevents Rh hemolytic disease in newborns.
PHOTO BY DARCY FIINLEY
43 WINTER 2022
Powered by FlippingBook